VITROS CHEMISTRY PRODUCTS DGXN SLIDES 8343386

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2018-12-04 for VITROS CHEMISTRY PRODUCTS DGXN SLIDES 8343386 manufactured by Ortho-clinical Diagnostics.

Event Text Entries

[130044557] The investigation concluded that lower than expected vitros digoxin (dgxn) results were obtained from a vitros performance verifier (pv) and a non-vitros (biorad) quality control (qc) fluid using vitros dgxn slide lot 1916-0251-2534 in combination with a vitros 250 chemistry system. The investigation determined the most likely assignable cause was user error, related to use of an expired on-analyzer reagent. Additionally, a calibration issue or a reagent issue could not be ruled out as contributing factors, as qc results do not meet expectations. Ongoing tracking and trending of complaint data has not identified any signals to suggest there is a systemic quality issue with vitros dgxn slide lot 1916-0251-2534. Within run precision testing meets expectations; therefore, the instrument can be ruled out as a contributing factor.
Patient Sequence No: 1, Text Type: N, H10


[130044558] A customer obtained lower than expected vitros digoxin (dgxn) results from a vitros performance verifier (pv) and a non-vitros (biorad) quality control (qc) fluid using vitros dgxn slide lot 1916-0251-2534, tested on a vitros 250 chemistry system. The results exceeded vitros dgxn potential health and safety criteria when compared to the center of the range of means for the pv and the center of the customer? S range for the non-vitros qc fluid. The results are provided below: vitros performance verifier ii (lot a6018) dgxn result of 1. 4 ng/ml vs. An expected result of 2. 15 ng/ml. Non-vitros biorad quality control fluid (lot 26422) dgxn results of 1. 38, 1. 95, 1. 87, 1. 89, 1. 95, 1. 93, and 1. 91 ng/ml vs. An expected result of 2. 98 ng/ml. Biased results of the direction and magnitude observed may lead to inappropriate physician action if undetected. The lower than expected vitros dgxn results were generated from non-patient fluids; however, the investigation cannot conclude that patient sample results would not be affected if the event were to recur undetected. Ortho has not been made aware of any allegation of actual patient harm as a result of the event. This report corresponds to ortho clinical diagnostics inc (ortho). Complaint numbers (b)(4).
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1319809-2018-00146
MDR Report Key8131015
Date Received2018-12-04
Date of Report2018-12-04
Date of Event2018-10-26
Date Mfgr Received2018-11-07
Device Manufacturer Date2018-08-24
Date Added to Maude2018-12-04
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. JAMES A STEVENS
Manufacturer Street100 INDIGO CREEK DRIVE
Manufacturer CityROCHESTER NY 14626
Manufacturer CountryUS
Manufacturer Postal14626
Manufacturer Phone5854533000
Manufacturer G1ORTHO-CLINICAL DIAGNOSTICS
Manufacturer Street513 TECHNOLOGY BLVD.
Manufacturer CityROCHESTER NY 14652
Manufacturer CountryUS
Manufacturer Postal Code14652
Single Use3
Previous Use Code3
Event Type3
Type of Report0

Device Details

Brand NameVITROS CHEMISTRY PRODUCTS DGXN SLIDES
Generic NameIN-VITRO DIAGNOSTIC
Product CodeLFM
Date Received2018-12-04
Catalog Number8343386
Lot Number1916-0251-2534
Device Expiration Date2019-07-15
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerORTHO-CLINICAL DIAGNOSTICS
Manufacturer Address100 INDIGO CREEK DRIVE ROCHESTER NY 14626 US 14626


Patients

Patient NumberTreatmentOutcomeDate
10 2018-12-04

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.